全文获取类型
收费全文 | 3227篇 |
免费 | 273篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 71篇 |
妇产科学 | 59篇 |
基础医学 | 894篇 |
口腔科学 | 115篇 |
临床医学 | 197篇 |
内科学 | 509篇 |
皮肤病学 | 68篇 |
神经病学 | 92篇 |
特种医学 | 34篇 |
外科学 | 241篇 |
综合类 | 646篇 |
现状与发展 | 1篇 |
预防医学 | 113篇 |
眼科学 | 112篇 |
药学 | 97篇 |
3篇 | |
中国医学 | 86篇 |
肿瘤学 | 265篇 |
出版年
2024年 | 8篇 |
2023年 | 63篇 |
2022年 | 78篇 |
2021年 | 129篇 |
2020年 | 107篇 |
2019年 | 88篇 |
2018年 | 92篇 |
2017年 | 110篇 |
2016年 | 96篇 |
2015年 | 132篇 |
2014年 | 170篇 |
2013年 | 234篇 |
2012年 | 133篇 |
2011年 | 148篇 |
2010年 | 127篇 |
2009年 | 138篇 |
2008年 | 166篇 |
2007年 | 173篇 |
2006年 | 152篇 |
2005年 | 127篇 |
2004年 | 116篇 |
2003年 | 115篇 |
2002年 | 99篇 |
2001年 | 89篇 |
2000年 | 69篇 |
1999年 | 70篇 |
1998年 | 64篇 |
1997年 | 75篇 |
1996年 | 37篇 |
1995年 | 26篇 |
1994年 | 36篇 |
1993年 | 30篇 |
1992年 | 27篇 |
1991年 | 29篇 |
1990年 | 23篇 |
1989年 | 21篇 |
1988年 | 22篇 |
1987年 | 22篇 |
1986年 | 16篇 |
1985年 | 15篇 |
1984年 | 17篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1977年 | 14篇 |
1976年 | 20篇 |
1975年 | 25篇 |
1974年 | 16篇 |
排序方式: 共有3620条查询结果,搜索用时 11 毫秒
71.
《Expert review of anticancer therapy》2013,13(6):917-934
The immune system has an intricate and complex relationship with tumorigenesis; while it has the capacity to identify and eliminate cancerous cells, the emergence of a tumor signifies its failure to do this. Thus, the immune–tumor interplay is paradoxical as through initial suppression of tumor growth, an immunologically silent or even suppressive tumor evolves. Furthermore, certain immune processes, such as chronic inflammation and immunosuppression, can facilitate malignant progression. Nevertheless, immunotherapeutic approaches can manipulate the immune milieu to improve the therapeutic outcomes of cancer treatments. Furthermore, particular conventional cancer therapies also have immunostimulatory properties in their own right. An in-depth understanding of the intimate involvement of the immune system in tumorigenesis and the potential to manipulate this interaction to improve disease outcomes will enable the development of new and broadly effective cancer therapies. 相似文献
72.
《Expert Review of Clinical Immunology》2013,9(7):777-789
ABSTRACTIntroduction: CD4 + T regulatory cells (Tregs) have been described as the most potent immunosuppressive cells in the human body. They have been found to control autoimmunity, and clinical attempts have been made to apply them to treat autoimmune diseases. Some specific pathways utilized by Tregs in the regulation of immune response or Tregs directly as cellular products are tested in the clinic.Areas covered: Here, we present recent advances in the research on the biology and clinical applications of Tregs in the treatment of autoimmune diseases.Expert opinion: Regulatory T cells seem to be a promising tool for the treatment of autoimmune diseases. The development of both cell-based therapies and modern pharmacotherapies which affect Tregs may strongly improve the treatment of autoimmune disorders. Growing knowledge about Treg biology together with the latest biotechnology tools may give an opportunity for personalized therapies in these conditions. 相似文献
73.
74.
Ten‐year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
An understanding of the differences in clinical manifestations and laboratory abnormalities between subtypes of cutaneous lupus erythematosus (CLE) is still lacking. The purpose of this study was to analyze demographic, clinical and histological features of CLE according to three main presentation subsets: acute (ACLE), subacute (SCLE) and chronic (CCLE). A 10‐year retrospective analysis was performed on data from patients who were diagnosed with CLE between March 2005 and September 2015 in a Korean tertiary referral dermatology clinic. We compared demographic data and clinical and histological findings between three different CLE groups. An overall sample of 220 patients with CLE consisted of 67 patients with ACLE, 25 patients with SCLE and 135 patients with CCLE. Patients with CCLE regardless of systemic lupus erythematosus (SLE) presence had lower prevalence of anemia, urinary abnormalities and elevated erythrocyte sedimentation rate. Furthermore, CCLE patients who only had skin lesions showed lower female predominance, lower extracutaneous manifestation, fewer laboratory and immunological abnormalities including low antinuclear antibody titers and the lowest positivity for C3, C4 and anti‐dsDNA, anti‐Ro, anti‐Sm and anti‐RNP antibodies, and more prominent perieccrine inflammation and dermal fibrosis in histological findings. Considering distinct cutaneous manifestations of LE, a comprehensive awareness of each CLE subtype is important for achieving a favorable prognosis through appropriate diagnosis and management. This study provides comparative clinical and histological profiles of patients with different CLE subtypes in Korea. 相似文献
75.
Histological immune response patterns in sentinel lymph nodes involved by metastatic melanoma and prognostic significance
下载免费PDF全文
![点击此处可从《Journal of cutaneous pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
76.
77.
Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
78.
Anti‐inflammatory effects of the GAG‐binding CXCL9(74‐103) peptide in dinitrofluorobenzene‐induced contact hypersensitivity in mice
下载免费PDF全文
![点击此处可从《Clinical and experimental allergy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
79.
Since the publication of the first textbook on autoimmune diseases in 1963, the knowledge in the field has exponentially grown into numerous tracks of research, particularly at benchside. Systemic and organ-specific autoimmune diseases, as in the case of the liver, have witnessed notable advances in terms of epidemiology, genetics, effector and regulatory mechanisms, and ultimately treatment. While the available tools for communication have provided accelerating progress rates, we recognize that key opinion leaders continue to provide significant contributions to the field. The present issue is dedicated to celebrate Giorgina Mieli-Vergani and Diego Vergani as two of the finest examples of excellence in autoimmune liver diseases and the broader field of autoimmunity. Diego and Giorgina are extremely well-liked Colleagues who fully represent the translational efforts between laboratory research and clinically relevant questions in the practice of pediatric liver diseases and autoimmune hepatitis. 相似文献
80.